Welcome to the Targeted Radiopharmaceuticals Manufacturing and Supply Chain Summit
The biggest challenges facing targeted radiopharmaceuticals are the highly complex processes associated with acquiring raw radioisotope APIs, the limited availability of these radionuclides, and getting whole-drug products to patients on time. This can’t be done alone! Abdera, Clarity, and Rayze have all recently landed landmark supply deals to fuel their clinical development and there are certainly more to come!
The Targeted Radiopharmaceuticals Manufacturing and Supply Chain Summit is the only industry-led meeting dedicated to plugging the gaps in radioisotope supply by developing new sources, designing manufacturing facilities that are scalable, and ensuring safety and quality through well-tested release criteria for whole drug products.
Join us as we unite 80+ key stakeholders in CMC, quality assurance, operations, facility managers, and radiopharmacists to bring the targeted radiotherapies to the forefront of cancer treatment.
Capitalizing on the recent successes this space had over the last year, there has never been this amount of demand and excitement for the TRP community. Take advantage of this platform to hear in-depth challenges and solutions in the global TRP manufacturing landscape.
Top 5 Benefits of Attending:
Establish more reliable supply chains to meet the needs of patients and the expectations of clinicians every time by implementing next-generation ordering systems, tracking technology and optimized processes with Bayer
Overcome stock issues of Lutetium and Actinium by taking advantage of the potential novel isotopes has, including Copper, Lead, Astatine, and Terbium with Convergent Therapeutics
Enhance the efficiency at your current sites, or scale up by learning from those that have led the way in GMP radiopharmaceutical manufacturing with Fusion Pharmaceuticals
Guarantee quality by updating your quality control release criteria with the most up-to-date information for a variety of isotopes, chelators and targeting systems with Radiomedix
Avoid making costly mistakes by ensuring you are up to date with rapidly changing regulations for isotopes, antibodies and whole drug products to avoid being slowed down with Earli
Your Expert Speakers Include:
Pharmaceutical Development and Regulatory Affairs Director
Chief Technical Officer
Chief Technology Officer BOD
Upcoming Event in the TRP Series:
Attain Significant Clinical Efficacy of Your TRP Pipeline by Matching Advances in Next Generation Targets with Innovations in Quantitative Imaging, Dosimetry Methods & Isotope Supply